Posttransplant recurrent FSGS: molecular insights and future directions.
Schachter
A D
AD
Departments of Pediatrics and Medicine, Harvard Medical School, Nephrology Division, Children's Hospital, Boston, Mass., USA.
Strom
T B
TB
D000808:Angiotensinogen / Q000096:biosynthesis; D015703:Antigens, CD / Q000378:metabolism; D002648:Child; D004268:DNA-Binding Proteins / Q000378:metabolism; D004351:Drug Resistance; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000517:prevention & control; D006801:Humans; D020672:I-kappa B Proteins; D016030:Kidney Transplantation / Q000009:adverse effects*; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism; D055502:Secondary Prevention; D013256:Steroids / Q000494:pharmacology
D015703:Antigens, CD; D004268:DNA-Binding Proteins; D020672:I-kappa B Proteins; D016328:NF-kappa B; C000606204:NFKBIA protein, human; D013256:Steroids; D000808:Angiotensinogen; D000072000:NF-KappaB Inhibitor alpha